Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Bloodstream Infection: early-phase trial registry
1 of 4 indexed Bloodstream Infection trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Bloodstream Infection: 4 US clinical trials tracked, 1 recruiting.
Bloodstream Infection is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is SNIPR Biome Aps., running 1 of these trials.
Enrollment posture brief
Registry condition bloodstream-infection
OPEN 1 | RECR 25% | LATE 0 | EARLY 2 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Bloodstream Infection lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Bloodstream Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Bloodstream Infection is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)
Boston Medical Center
NCT06489535
Next Generation Pathogen Sequencing for Prediction of Adverse Events
St. Jude Children's Research Hospital
NCT03226158
A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects
SNIPR Biome Aps.
NCT05277350
Catheter Related - Gram Positive Bloodstream Infections
M.D. Anderson Cancer Center
NCT00467272
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Bloodstream Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Bloodstream Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Bloodstream Infection page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Bloodstream Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- SNIPR Biome Aps. sponsors the most Bloodstream Infection trials on record, review their full trial history before evaluating a specific study. See SNIPR Biome Aps.'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bloodstream Infection condition card totals 4 registered trials; most-linked intervention Daptomycin; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.